Surgery News and Research

RSS

STAAR Surgical to market Visian ICL with CentraFLOW technology in Korea, Argentina

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has received regulatory approvals to market its Visian Implantable Collamer Lens with CentraFLOW technology from the KFDA in Korea and the ANMAT in Argentina.

17 Jun 2013

NGM, MedImmune partner to develop novel therapeutics for treatment of diabetes and obesity

NGM Biopharmaceuticals, Inc. and MedImmune, the global biologics research and development arm of AstraZeneca, announced today that they have entered into an exclusive agreement to discover, develop and commercialize novel therapeutics from NGM's enteroendocrine cell program for the treatment of type 2 diabetes and obesity.

17 Jun 2013

Athera receives support from FP7 for development of fully human antibody PC-mAb

Athera Biotechnologies AB today announced that future development costs of its fully human antibody PC-mAb up until proof-of-concept will be co-funded by the European Union's Seventh Framework Programme for Research (FP7) through a collaborative research grant. Karolinska Development AB owns 65% of Athera Biotechnologies AB.

17 Jun 2013

Investigators recruit subjects for Boston Children's Hand Transplant Program

Boston Children's Hospital today announced that investigators are now recruiting subjects for the world's first pediatric hand transplant program. The Boston Children's Hand Transplant Program, led by principal investigator Amir Taghinia, MD, and William Harmon, MD, is a research-based program that will offer bi-lateral hand transplants for children living without two functioning hands.

17 Jun 2013

FDA approves MENTOR MemoryShape Breast Implants

Mentor Worldwide LLC, the U.S. market leader in breast aesthetics, today announced the U.S. Food and Drug Administration has approved MENTOR MemoryShape Breast Implants, providing new options for women looking for a more natural shape and youthful feel from breast enhancement or reconstruction surgery.

15 Jun 2013

July 4th: An outstanding time to declare independence from severe obesity

If you're considering weight loss surgery, Beverly Hills Physicians has some very special thoughts for you as we approach Independence Day 2013. Serious obesity is never easy, but it can be especially difficult during the summer. Hikes, picnics, pool parties, even out of town vacations can be a lot more difficult if you're dealing with the discomfort and health problems that go with being extremely overweight. Still, sometimes the things that make us uncomfortable also spur us into action.

15 Jun 2013

Study seeks answers for why youth baseball pitching injuries continue to rise despite pitching limits

After three years of research, a multicenter, national research study led by Beaumont orthopedic surgeon and sports medicine specialist, Joseph Guettler, M.D., may have some answers as to why youth baseball pitching injuries continue to rise despite the implementation of nationally recommended pitching limits.

15 Jun 2013

Anatomy of a Hospital: New book chronicles history of nation's oldest hospital for orthopedics

With 537 pages and 150 photographs, "Anatomy of a Hospital" chronicles the history of the nation's oldest hospital for orthopedics, from its beginnings in a doctor's home to help destitute children with disabilities to the premier hospital it has become today.

15 Jun 2013

pSivida reports that NICE issues draft guidance for use of ILUVIEN for pseudophakic patients with DME

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the United Kingdom's National Institute for Health and Care Excellence issued draft guidance recommending ILUVIEN for the treatment of pseudophakic patients (those who have undergone prior cataract surgery) with chronic diabetic macular edema considered insufficiently responsive to available therapies.

15 Jun 2013

New state-of-the-art SmileBest Dental & Orthodontics office opens in Hurst

Soumava Sen, D.D.S. is pleased to announce the opening of his state-of-the-art SmileBest Dental & Orthodontics office in Hurst. Dr. Sen is proud to be supported by SmileBest Dental Services, L.L.C., a provider of business and administrative support services and systems to dental practices, including low-exposure digital X-rays, electronic dental records, digital intra-oral cameras and much more.

15 Jun 2013

Hospitalized patients do not receive blood thinners to prevent blood clots, researchers report

Researchers at Johns Hopkins report that hospitalized patients do not receive more than one in 10 doses of doctor-ordered blood thinners prescribed to prevent potentially lethal or disabling blood clots, a decision they say may be fueled by misguided concern by patients and their caregivers.

15 Jun 2013

MemoryShape Breast Implants receive FDA approval

The U.S. Food and Drug Administration today approved the MemoryShape Breast Implant to increase breast size (augmentation) for use in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age.

15 Jun 2013

Research: Deep brain stimulation is associated with weight loss trend in morbidly obese patients

The first use of deep brain stimulation to the brain's so-called "feeding center" - the lateral hypothalamic area (LHA) - was associated with a weight loss trend in morbidly obese patients whose stimulation was tuned to increase metabolism with novel guidance from metabolic chamber data, according to a pilot study presented at the International Neuromodulation Society's 11th World Congress by Dr. Michael Oh of the Department of Neurosurgery at the Allegheny General Hospital in Pittsburgh, Pa.

14 Jun 2013

New drug target may prevent consequences of ACL tear in athletes

Striking the likes of Chicago Bulls' Derrick Rose, L.A. Lakers' Kobe Bryant and Detroit Tigers' Victor Martinez, tears in the anterior cruciate ligament (ACL) are one of the most rampant and serious knee injuries among athletes.

14 Jun 2013

NICE Appraisal Committee reconfirms clinical effectiveness of ILUVIEN

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the Appraisal Committee of the United Kingdom's National Institute for Health and Care Excellence has issued a positive Appraisal Consultation Document on ILUVIEN for the treatment of pseudophakic patients with chronic diabetic macular edema considered insufficiently responsive to available therapies.

14 Jun 2013

Clear Lake Regional Medical Center opens new tower to better serve Bay Area Houston community

Clear Lake Regional Medical Center today celebrated the grand opening of its $92 million expansion project that will enhance services to better serve the Bay Area Houston community.

14 Jun 2013

Penn Medicine researchers identify key molecular player in recurrent breast cancer

According to the American Cancer Society, nearly 40,000 women in the United States will succumb to breast cancer this year. Most of these women will die not from the primary tumor but rather tumor recurrence - the reappearance of the disease following treatment.

14 Jun 2013

Xgeva receives FDA approval for treating giant cell tumor of the bone

The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone, a rare and usually non-cancerous tumor.

14 Jun 2013

Next-generation self-expanding clot removal device from Codman Neuro obtains CE mark

Codman Neuro*, part of DePuy Synthes Companies of Johnson & Johnson, has obtained CE marking for REVIVE SE, a next-generation self-expanding clot removal device for use in treating acute ischemic stroke, the company announced today at the Live Interventional Neuroradiology & Neurosurgery Course (LINNC) in Paris.

13 Jun 2013

NACC recommendations address established pain therapies and preview potential future advances

Recommendations of the Neuromodulation Appropriateness Consensus Committee (NACC), announced at the 11th World Congress of the International Neuromodulation Society (INS), address established therapies and preview emerging and potential future advances.

13 Jun 2013

Surgery News and Research

STAAR Surgical to market Visian ICL with CentraFLOW technology in Korea, Argentina

NGM, MedImmune partner to develop novel therapeutics for treatment of diabetes and obesity

Athera receives support from FP7 for development of fully human antibody PC-mAb

Investigators recruit subjects for Boston Children's Hand Transplant Program

FDA approves MENTOR MemoryShape Breast Implants

July 4th: An outstanding time to declare independence from severe obesity

Study seeks answers for why youth baseball pitching injuries continue to rise despite pitching limits

Anatomy of a Hospital: New book chronicles history of nation's oldest hospital for orthopedics

pSivida reports that NICE issues draft guidance for use of ILUVIEN for pseudophakic patients with DME

New state-of-the-art SmileBest Dental & Orthodontics office opens in Hurst

Hospitalized patients do not receive blood thinners to prevent blood clots, researchers report

MemoryShape Breast Implants receive FDA approval

Research: Deep brain stimulation is associated with weight loss trend in morbidly obese patients

New drug target may prevent consequences of ACL tear in athletes

NICE Appraisal Committee reconfirms clinical effectiveness of ILUVIEN

Clear Lake Regional Medical Center opens new tower to better serve Bay Area Houston community

Penn Medicine researchers identify key molecular player in recurrent breast cancer

Xgeva receives FDA approval for treating giant cell tumor of the bone

Next-generation self-expanding clot removal device from Codman Neuro obtains CE mark

NACC recommendations address established pain therapies and preview potential future advances

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News